Incyte
Wilmington · Founded 1991
About Incyte
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with [Novartis](/organization/novartis), [Eli Lilly](/organization/eli-lilly), and [Pfizer](/organization/pfizer), Incyte intends to promote the clinical development and global commercialization of several of their compounds.
Company Facts
- Founded: 1991
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Ticker: nasdaq:INCY
- Website: incyte.com
- Phone: 855-463-3463
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/incyte-7114 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.